Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 25 Mcg (0.025 Mg), 100 Tablets (10 X 10 Unit Dose Blisters) Per Carton
Major Pharmaceuticals is recalling 25 mcg Levothyroxine Sodium Tablets (NDC: 0904-6949-61) distributed nationwide because the tablets contain less active ingredient than labeled, making them subpotent. This recall affects patients who may have received this thyroid medication in all 50 states and Washington, D.C.
- Recalling firm
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6949-61
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-13
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/8cdaf420-d232-488c-9313-ddcd0960ce96